Saturday, June 11, 2016 11:16:33 AM
It certainly does look that you will be proven right. How can anyone here disagree with your assessment is beyond me, many here seem to feel more comfortable sticking there head in the sand than see what they need to take note of. It is obvious that NWBO can be sacrificed for the good of cognate allowing the ceo to continue on their merry way IMHO.
No ceo who intends to preserve a co allows their pps to collapse to penny stock levels unless there is a reason, in this case there is another co that can continue. Tell me how I am wrong please, the only losers are the small amount of shareholders. I am ready to write this off, thank goodness I need losses so at least it isn't a total loss.
All the projecting and investigating by members here are well and good and impressive at times but my feat will be that if they turn out to have figured it all out any success will only benefit the company that isn't partially owned by shareholders.
This is all my personal opinion.
Prove me wrong, I sure hope I am wrong but from where I stand at .65C it appears I am seeing things for what they are and you all aren't.
No ceo who intends to preserve a co allows their pps to collapse to penny stock levels unless there is a reason, in this case there is another co that can continue. Tell me how I am wrong please, the only losers are the small amount of shareholders. I am ready to write this off, thank goodness I need losses so at least it isn't a total loss.
All the projecting and investigating by members here are well and good and impressive at times but my feat will be that if they turn out to have figured it all out any success will only benefit the company that isn't partially owned by shareholders.
This is all my personal opinion.
Prove me wrong, I sure hope I am wrong but from where I stand at .65C it appears I am seeing things for what they are and you all aren't.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
